Geneos Therapeutics Raises $12M in Series A1 Financing

10 Mar, 2021

Geneos Therapeutics Raises $12M in Series A1 Financing
Photo by Marten Bjork on Unsplash

– Geneos Therapeutics from Plymouth Meeting, Pa. develops personalized neoantigen-targeting immunotherapies for cancer.
– The company raised $12m in Series A1 funding.
– The round was led by Korea Investment Partners (KIP) – Global Bio Fund with participation from existing investors Santé Ventures and Inovio Pharmaceuticals, Inc. (NASDAQ: INO).
– The company plans to use the funds for the expansion of the company’s:
– GT-30 Phase Ib/IIa clinical trial evaluating its personalized neoantigen-targeting vaccine,

Biotechnology Health Care North America Pharmaceutical Therapeutics
Crunchbase icon

Content report

The following text will be sent to our editors: